__timestamp | Bausch Health Companies Inc. | Vertex Pharmaceuticals Incorporated |
---|---|---|
Wednesday, January 1, 2014 | 2254600000 | 60987000 |
Thursday, January 1, 2015 | 2645000000 | 125542000 |
Friday, January 1, 2016 | 2611000000 | 210460000 |
Sunday, January 1, 2017 | 2548000000 | 275119000 |
Monday, January 1, 2018 | 2351000000 | 409539000 |
Tuesday, January 1, 2019 | 2350000000 | 547758000 |
Wednesday, January 1, 2020 | 2249000000 | 736300000 |
Friday, January 1, 2021 | 2394000000 | 904200000 |
Saturday, January 1, 2022 | 2364000000 | 1080300000 |
Sunday, January 1, 2023 | 2559000000 | 1262200000 |
Monday, January 1, 2024 | 1530500000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. Over the past decade, Bausch Health Companies Inc. and Vertex Pharmaceuticals Incorporated have showcased contrasting expense trends. From 2014 to 2023, Bausch Health's cost of revenue remained relatively stable, averaging around $2.4 billion annually, with a slight increase of approximately 13% by 2023. In contrast, Vertex Pharmaceuticals experienced a dramatic rise, with costs surging over 1,900% from $61 million in 2014 to $1.26 billion in 2023. This stark difference highlights Vertex's aggressive growth strategy and increased production capabilities. As the pharmaceutical landscape continues to shift, these insights provide a window into the financial strategies of two industry giants, offering valuable lessons for emerging companies and investors alike.
Analyzing Cost of Revenue: AbbVie Inc. and Bausch Health Companies Inc.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Jazz Pharmaceuticals plc
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Alkermes plc's Expenses
Who Generates More Revenue? Vertex Pharmaceuticals Incorporated or Bausch Health Companies Inc.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
GSK plc vs Bausch Health Companies Inc.: Efficiency in Cost of Revenue Explored
BioMarin Pharmaceutical Inc. vs Bausch Health Companies Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Perrigo Company plc and Bausch Health Companies Inc.
Comparing Cost of Revenue Efficiency: Bausch Health Companies Inc. vs Wave Life Sciences Ltd.
Cost of Revenue Comparison: Bausch Health Companies Inc. vs Evotec SE